U.S. Markets open in 2 hrs 43 mins

BioMarin Pharmaceutical Inc. (BMRN)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
88.63-1.38 (-1.53%)
At close: 4:00PM EDT
People also watch
ALXNVRTXREGNINCYBIIB
Full screen
Previous Close90.01
Open90.50
Bid87.60 x 100
Ask94.90 x 100
Day's Range88.33 - 90.50
52 Week Range78.42 - 102.49
Volume1,004,926
Avg. Volume1,273,022
Market Cap15.47B
Beta1.96
PE Ratio (TTM)-26.40
EPS (TTM)-3.36
Earnings DateAug 2, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est113.67
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to BioMarin Pharmaceutical, Inc. : July 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to BioMarin Pharmaceutical, Inc. Here are 5 ETFs with the largest exposure to BMRN-US. Comparing the performance and risk of BioMarin Pharmaceutical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Zacks6 days ago

    Sarepta Therapeutics (SRPT) Stock Surged 24% Today: Here's Why

    On Thursday, shares of Sarepta Therapeutics (SRPT) are surging, up almost 24% to $42.14 per share in morning trading after the biotech company reported second-quarter revenues that blew past expectations in its earnings report yesterday after the bell.

  • Sarepta & BioMarin Settle Patent Litigation on Exon Skipping
    Zacks7 days ago

    Sarepta & BioMarin Settle Patent Litigation on Exon Skipping

    Sarepta Therapeutics, Inc. (SRPT), and BioMarin Pharmaceutical Inc., have settled their ongoing global patent litigation pertaining to exon skipping technology used in Duchenne muscular dystrophy therapies.